Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Neoplasms, Malignant

Interventions

DRUG

ombrabulin (AVE8062)

"Pharmaceutical form:injection solution~Route of administration: intravenous infusion"

DRUG

cisplatin

"Pharmaceutical form: injection solution~Route of administration: intravenous infusion"

Trial Locations (1)

Sanofi-Aventis Administrative Office, Tokyo